Trial to Evaluate the Efficacy on Glycemic Variability and Safety of Gemigliptin Compared With Dapagliflozin Added on Metformin Alone or Diabetes Medication Naïve Patient in Type 2 Diabetes Mellitus (Stable II Study)

NCT03202563 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Gemigliptin 50mg
DRUG: Dapagliflozin 10mg
PROCEDURE: Diet/exercise questionnaire
DEVICE: Continuous Glucose Monitoring System(CGMS)
DRUG: Metformin

Sponsor

LG Chem